Day One Biopharmaceuticals (DAWN)
(Real Time Quote from BATS)
$12.77 USD
-0.29 (-2.22%)
Updated Jun 6, 2024 11:43 AM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
Day One Biopharmaceuticals, Inc. [DAWN]
Reports for Purchase
Showing records 61 - 71 ( 71 total )
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q Financials; FIREFLY-1 Hits Target Enrollment; Initial Data Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Data Readouts for DAY101 in 1H2022
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q2 Financials; First Patients Dosed in FIREFLY-1
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM and $30; Good Morning Targeted Oncology
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R